Cara Therapeutics (CARA) Short Interest Ratio & Short Volume $5.22 -0.14 (-2.61%) As of 01/3/2025 05:39 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cara Therapeutics Short Interest DataCara Therapeutics (CARA) has a short interest of 329,400 shares, representing 0.72% of the float (the number of shares available for trading by the public). This marks a -42.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 110,359 shares to cover all short positions.Current Short Interest329,400 sharesPrevious Short Interest576,700 sharesChange Vs. Previous Month-42.88%Dollar Volume Sold Short$86,302.80Short Interest Ratio0.2 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares4,569,000 sharesFloat Size45,770,000 sharesShort Percent of Float0.72%Today's Trading Volume92,519 sharesAverage Trading Volume110,359 sharesToday's Volume Vs. Average84% Short Selling Cara Therapeutics? Sign up to receive the latest short interest report for Cara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCARA Short Interest Over TimeCARA Days to Cover Over TimeCARA Percentage of Float Shorted Over Time Cara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024329,400 shares $86,302.80 -42.9%0.7%0.2 $0.26 11/30/2024576,700 shares $175,316.80 -54.2%1.3%1.1 $0.30 11/15/20241,260,000 shares $391,986.00 +33.7%2.8%2.5 $0.31 10/31/2024942,500 shares $292,552.00 +54.6%2.1%2 $0.31 10/15/2024609,700 shares $155,473.50 -26.7%1.3%1.9 $0.26 9/30/2024832,200 shares $256,317.60 -31.2%1.8%1.6 $0.31 Get the Latest News and Ratings for CARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20241,210,000 shares $317,625.00 +9.0%2.6%1.7 $0.26 8/31/20241,110,000 shares $399,600.00 -24.0%2.4%1.3 $0.36 8/15/20241,460,000 shares $474,500.00 +73.2%3.2%1.7 $0.33 7/31/2024842,900 shares $293,413.49 +37.4%1.9%1 $0.35 7/15/2024613,400 shares $205,489.00 -68.2%1.4%0.7 $0.34 6/30/20241,930,000 shares $497,940.00 -15.0%4.2%2.8 $0.26 6/15/20242,270,000 shares $794,500.00 -1.3%5.0%3.9 $0.35 5/31/20242,300,000 shares $1.49 million -5.7%5.1%6 $0.65 5/15/20242,440,000 shares $1.85 million -6.5%5.2%4.4 $0.76 4/30/20242,610,000 shares $1.96 million No Change5.6%4.4 $0.75 4/15/20242,610,000 shares $1.85 million +1.2%5.6%4.1 $0.71 3/31/20242,580,000 shares $2.35 million +4.0%5.6%3.7 $0.91 3/15/20242,480,000 shares $2.18 million +3.8%5.3%3.1 $0.88 2/29/20242,390,000 shares $2.03 million +7.2%5.2%2.5 $0.85 2/15/20242,230,000 shares $1.33 million -11.2%4.8%2.5 $0.60 1/31/20242,510,000 shares $1.42 million +5.5%5.4%3.2 $0.57 1/15/20242,380,000 shares $1.36 million +3.0%5.1%3.1 $0.57 12/31/20232,310,000 shares $1.72 million +6.5%5.0%3.1 $0.74 12/15/20232,170,000 shares $2.67 million -38.9%4.7%3.2 $1.23 11/30/20233,550,000 shares $3.43 million +3.8%7.7%6.2 $0.97 11/15/20233,420,000 shares $3.83 million +15.2%7.4%5.6 $1.12 10/31/20232,970,000 shares $3.83 million +9.6%6.6%5 $1.29 10/15/20232,710,000 shares $3.85 million +9.7%6.0%4.1 $1.42 9/30/20232,470,000 shares $4.15 million +10.3%5.5%3.5 $1.68 9/15/20232,240,000 shares $5.24 million +44.5%5.0%2 $2.34 8/31/20231,550,000 shares $3.98 million -40.8%3.5%1.2 $2.57 8/15/20232,620,000 shares $7.86 million -24.5%5.8%1.9 $3.00 7/31/20233,470,000 shares $11.56 million -12.6%8.1%2.5 $3.33 7/15/20233,970,000 shares $11.35 million +6.7%9.3%2.9 $2.86 6/30/20233,720,000 shares $10.53 million -35.3%8.7%2.8 $2.83 6/15/20235,750,000 shares $18.57 million +12.5%13.5%5.9 $3.23 5/31/20235,110,000 shares $16.25 million +2.0%12.0%6.8 $3.18 5/15/20235,010,000 shares $20.79 million No Change11.7%6.8 $4.15 4/30/20235,010,000 shares $21.04 million +3.5%11.9%7.5 $4.20 4/15/20234,840,000 shares $20.47 million -9.4%11.4%7.5 $4.23 3/31/20235,340,000 shares $26.22 million +3.9%12.6%8.6 $4.91 3/15/20235,140,000 shares $29.61 million -6.4%12.2%8.7 $5.76 2/28/20235,490,000 shares $55.78 million -1.4%13.0%11 $10.16 2/15/20235,570,000 shares $57.71 million +3.9%13.3%15.2 $10.36 1/31/20235,360,000 shares $62.60 million +6.4%12.8%15.3 $11.68 1/15/20235,040,000 shares $54.68 million +1.6%12.0%14.1 $10.85 12/30/20224,960,000 shares $53.27 million -10.8%11.8%13.8 $10.74 12/15/20225,560,000 shares $62.11 million -0.4%13.2%16.4 $11.17 11/30/20225,580,000 shares $65.84 million -9.4%13.3%16.5 $11.80 11/15/20226,160,000 shares $69.79 million -1.8%14.7%18.1 $11.33 10/31/20226,270,000 shares $58.94 million -1.7%14.9%17.1 $9.40 10/15/20226,380,000 shares $64.82 million -3.6%15.2%16.4 $10.16 9/30/20226,620,000 shares $61.96 million -7.2%15.8%16.4 $9.36 9/15/20227,130,000 shares $73.65 million No Change17.0%16.5 $10.33 8/31/20227,130,000 shares $73.58 million -0.7%17.0%16.4 $10.32 8/15/20227,180,000 shares $84.37 million -0.8%17.1%15.1 $11.75 7/31/20227,240,000 shares $63.28 million +3.0%16.3%12.6 $8.74 7/15/20227,030,000 shares $65.03 million +8.2%15.8%11.4 $9.25 6/30/20226,500,000 shares $59.35 million +3.5%14.6%10 $9.13 6/15/20226,280,000 shares $49.86 million +3.6%14.1%9.8 $7.94 5/31/20226,060,000 shares $50.42 million +13.3%13.6%9.1 $8.32 5/15/20225,350,000 shares $44.94 million +30.2%12.0%7.8 $8.40 4/30/20224,110,000 shares $35.84 million -2.4%9.2%6.9 $8.72 4/15/20224,210,000 shares $58.27 million +2.9%9.5%7.7 $13.84 3/31/20224,090,000 shares $49.69 million +1.0%9.2%8.2 $12.15 3/15/20224,050,000 shares $46.37 million +29.4%9.1%8.4 $11.45 2/28/20223,130,000 shares $32.46 million +25.2%7.1%6.3 $10.37 2/15/20222,500,000 shares $26.43 million +50.6%5.7%5.1 $10.57 1/31/20221,660,000 shares $19.22 million -4.6%3.8%3.2 $11.58 1/15/20221,740,000 shares $20.79 million -7.0%N/A0 $11.95 12/31/20211,870,000 shares $22.78 million -9.7%4.2%2.8 $12.18 12/15/20212,070,000 shares $25.83 million -19.8%4.7%3.1 $12.48 11/30/20212,580,000 shares $34.00 million +4.5%5.9%3.7 $13.18 11/15/20212,470,000 shares $38.63 million -14.8%5.6%2.7 $15.64 10/29/20212,900,000 shares $48.81 million +37.4%7.3%1.8 $16.83 10/15/20212,110,000 shares $27.77 million -0.5%5.3%1.4 $13.16 9/30/20212,120,000 shares $32.75 million -30.3%5.3%1.4 $15.45 9/15/20213,040,000 shares $44.90 million -21.5%7.6%2 $14.77 8/31/20213,870,000 shares $61.07 million +29.4%9.6%2.6 $15.78 8/13/20212,990,000 shares $41.41 million -2.0%7.4%4.3 $13.85 7/30/20213,050,000 shares $36.51 million No Change7.8%5.4 $11.97 7/15/20213,050,000 shares $39.47 million -3.8%7.8%3.6 $12.94 6/30/20213,170,000 shares $45.24 million -10.5%8.1%3.4 $14.27 6/15/20213,540,000 shares $50.20 million +12.4%9.0%2.8 $14.18 5/28/20213,150,000 shares $42.81 million -11.8%8.0%2.5 $13.59 5/14/20213,570,000 shares $45.98 million -7.8%9.1%2.9 $12.88 4/30/20213,870,000 shares $54.45 million +8.1%9.9%3 $14.07 4/15/20213,580,000 shares $102.10 million +30.7%9.3%3.8 $28.52 3/31/20212,740,000 shares $56.42 million -14.6%7.1%3.1 $20.59 3/15/20213,210,000 shares $61.95 million +4.6%8.3%6.3 $19.30 2/26/20213,070,000 shares $59.13 million +9.6%7.9%6.1 $19.26 2/12/20212,800,000 shares $55.75 million -4.4%7.2%5.8 $19.91 1/29/20212,930,000 shares $54.15 million -18.2%7.6%6.5 $18.48 1/15/20213,580,000 shares $64.62 million -6.8%9.2%8.2 $18.05 12/31/20203,840,000 shares $59.06 million -3.0%9.9%9.3 $15.38 12/15/20203,960,000 shares $59.00 million +2.9%10.2%9.3 $14.90 11/30/20203,850,000 shares $57.56 million +0.5%9.9%9.1 $14.95 11/15/20203,830,000 shares $59.02 million No Change10.1%9.3 $15.41 10/30/20203,830,000 shares $50.44 million -15.3%10.7%9.8 $13.17 10/15/20204,520,000 shares $60.52 million +2.5%12.6%11.6 $13.39 9/30/20204,410,000 shares $56.12 million +14.8%10.3%11.7 $12.73 9/15/20203,840,000 shares $58.56 million +2.4%9.0%10.3 $15.25 8/31/20203,750,000 shares $58.13 million +2.7%8.8%9.3 $15.50 8/14/20203,650,000 shares $59.46 million -1.1%8.5%8.5 $16.29 7/31/20203,690,000 shares $60.66 million -3.2%8.7%7.6 $16.44 7/15/20203,810,000 shares $68.28 million -5.0%9.0%7.4 $17.92 6/30/20204,010,000 shares $67.29 million +12.0%9.5%7.4 $16.78 6/15/20203,580,000 shares $55.56 million -2.2%8.5%6.6 $15.52 5/29/20203,660,000 shares $58.08 million -2.1%8.6%6.7 $15.87 5/15/20203,740,000 shares $56.25 million +14.0%8.8%6.6 $15.04 4/30/20203,280,000 shares $48.61 million -6.0%7.7%6.4 $14.82 4/15/20203,490,000 shares $48.62 million -5.4%8.2%6.8 $13.93 3/31/20203,690,000 shares $58.45 million -13.2%8.7%6.9 $15.84 3/13/20204,251,500 shares $58.54 million -1.6%12.2%8.2 $13.77 2/28/20204,320,000 shares $47.78 million +0.2%12.4%7.2 $11.06 2/14/20204,310,000 shares $60.25 million -5.5%10.2%5.9 $13.98 1/31/20204,560,000 shares $72.32 million -6.0%10.7%6.2 $15.86 1/15/20204,850,000 shares $83.81 million -9.7%11.4%6.6 $17.28 CARA Short Interest - Frequently Asked Questions What is Cara Therapeutics' current short interest? Short interest is the volume of Cara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 329,400 shares of CARA short. 0.72% of Cara Therapeutics' shares are currently sold short. Learn More on Cara Therapeutics' current short interest. What is a good short interest percentage for Cara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.72% of Cara Therapeutics' floating shares are currently sold short. Is Cara Therapeutics' short interest increasing or decreasing? Cara Therapeutics saw a drop in short interest in December. As of December 15th, there was short interest totaling 329,400 shares, a drop of 42.9% from the previous total of 576,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cara Therapeutics' float size? Cara Therapeutics currently has issued a total of 4,569,000 shares. Some of Cara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cara Therapeutics currently has a public float of 45,770,000 shares. How does Cara Therapeutics' short interest compare to its competitors? 0.72% of Cara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cara Therapeutics: Theratechnologies Inc. (0.38%), ESSA Pharma Inc. (2.14%), Anixa Biosciences, Inc. (1.06%), Scilex Holding (3.29%), CytomX Therapeutics, Inc. (7.08%), Atara Biotherapeutics, Inc. (13.04%), Context Therapeutics Inc. (1.67%), Entera Bio Ltd. (0.17%), Aerovate Therapeutics, Inc. (9.49%), Ikena Oncology, Inc. (0.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Cara Therapeutics stock? Short selling CARA is an investing strategy that aims to generate trading profit from Cara Therapeutics as its price is falling. CARA shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cara Therapeutics? A short squeeze for Cara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARA, which in turn drives the price of the stock up even further. How often is Cara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARA, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies THTX Short Interest EPIX Short Interest ANIX Short Interest SCLX Short Interest CTMX Short Interest ATRA Short Interest CNTX Short Interest ENTX Short Interest AVTE Short Interest IKNA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CARA) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CARA Stock Alerts